Prebiotics feed the beneficial bacteria already in your gut
In a subgroup of patients that became hypoglycemic during the baseline mixed meal challenge, across all doses of mizagliflozin (combined), compared with baseline, the glucose nadir was raised by 19.3 mg/dL (38%) (p=0.03), the glucose peak was lowered by -36.3 mg/dL (21%) (p=0.03), and the insulin peak was lowered by -324.5 IU/mL (53%) (p=0.016)
501,502 Clinical trials demonstrated a clinical remission rate of 18.7% at 8 weeks and 27.6% at 24 weeks in patients treated with ustekinumab, with an adverse event rate of 2.3%
Tirzepatide has advantages over other peptides, demonstrating promising results
This article outlines the key contraindications, precautions, and safety considerations to help patients and healthcare professionals make informed decisions about treatment suitability
Red Blood Cell Formation: It assists in producing healthy red blood cells, reducing the risk of anemia